Data / Drug companies / Malladi Drugs & Pharmaceuticals Limited
Malladi Drugs & Pharmaceuticals Limited: 27 products in the FDA NDC directory, labeler code 57218
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Malladi Drugs & Pharmaceuticals Limited (labeler code 57218) lists 27 products in the FDA National Drug Code Directory. By type: 27 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on November 4, 2025.
The request: Watch Malladi Drugs & Pharmaceuticals Limited (FDA labeler code 57218): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 57218
- Products in commercial distribution
- 27
- Packages
- 42
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 4
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 1, 1995
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 27 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 27 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 27 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Minoxidil | 57218-956 | Powder | Bulk ingredients | November 4, 2025 |
| Phenylpropanolamine hydrochloride | 57218-957 | Powder | Bulk ingredients | October 23, 2025 |
| Butorphanol tartrate | 57218-954 | Powder | Bulk ingredients | March 13, 2025 |
| Phentermine hydrochloride | 57218-953 | Powder | Bulk ingredients | November 18, 2024 |
| Doxylamine succinate | 57218-952 | Powder | Bulk ingredients | November 1, 2022 |
| Tranexamic acid | 57218-951 | Powder | Bulk ingredients | December 29, 2020 |
| Ephedrine base | 57218-154 | Powder | Bulk ingredients | January 8, 2018 |
| Ephedrine sulfate | 57218-937 | Powder | Bulk ingredients | December 29, 2017 |
| Amlodipine besylate | 57218-936 | Powder | Bulk ingredients | August 7, 2017 |
| Pyrilamine maleate | 57218-755 | Powder | Bulk ingredients | June 2, 2017 |
| Chlorpheniramine maleate | 57218-765 | Powder | Bulk ingredients | April 18, 2017 |
| Dextromethorphan hydrobromide | 57218-760 | Powder | Bulk ingredients | February 28, 2017 |
| Metaraminol bitartrate | 57218-750 | Powder | Bulk ingredients | January 15, 2017 |
| 4-methyl-5-phenyl-2-oxazolidinone, (4s,5r)- | 57218-931 | Powder | Bulk ingredients | January 10, 2014 |
| 4-methyl-5-phenyl-2-oxazolidinone, cis- | 57218-930 | Powder | Bulk ingredients | January 10, 2014 |
| Phenylephrine bitartrate | 57218-820 | Powder | Bulk ingredients | January 1, 2012 |
| Lorazepam | 57218-950 | Powder | Bulk ingredients | January 1, 2009 |
| Alprazolam | 57218-312 | Powder | Bulk ingredients | January 1, 2008 |
| Phenylephrine | 57218-710 | Powder | Bulk ingredients | January 1, 2007 |
| Phenylephrine hydrochloride | 57218-810 | Powder | Bulk ingredients | January 1, 2005 |
| Ephedrine sulfate | 57218-511 | Powder | Bulk ingredients | January 1, 2005 |
| Ephedrine | 57218-151 | Powder | Bulk ingredients | January 1, 2005 |
| Triprolidine hydrochloride | 57218-900 | Powder | Bulk ingredients | January 1, 2003 |
| Pseudoephedrine | 57218-500 | Powder | Bulk ingredients | January 1, 2003 |
| Pseudoephedrine hydrochloride | 57218-801 | Powder | Bulk ingredients | January 1, 1995 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.